These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 28808418)

  • 1. Emerging roles of SIRT1 in fatty liver diseases.
    Ding RB; Bao J; Deng CX
    Int J Biol Sci; 2017; 13(7):852-867. PubMed ID: 28808418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease.
    Colak Y; Ozturk O; Senates E; Tuncer I; Yorulmaz E; Adali G; Doganay L; Enc FY
    Med Sci Monit; 2011 May; 17(5):HY5-9. PubMed ID: 21525818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirtuin 1 deacetylase: a key regulator of hepatic lipid metabolism.
    Kemper JK; Choi SE; Kim DH
    Vitam Horm; 2013; 91():385-404. PubMed ID: 23374725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of pure total flavonoids from citrus on hepatic SIRT1/PGC-1alpha pathway in mice with NASH].
    Chen ZY; Li JS; Jiang JP; Yan MX; He BH
    Zhongguo Zhong Yao Za Zhi; 2014 Jan; 39(1):100-5. PubMed ID: 24754177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential treatment of non-alcoholic fatty liver disease with SIRT1 activators.
    Colak Y; Yesil A; Mutlu HH; Caklili OT; Ulasoglu C; Senates E; Takir M; Kostek O; Yilmaz Y; Yilmaz Enc F; Tasan G; Tuncer I
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):311-9. PubMed ID: 25267960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calorie restriction on insulin resistance and expression of SIRT1 and SIRT4 in rats.
    Chen YR; Fang SR; Fu YC; Zhou XH; Xu MY; Xu WC
    Biochem Cell Biol; 2010 Aug; 88(4):715-22. PubMed ID: 20651844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of silent information regulator 1 activity in noncancerous tissues of hepatocellular carcinoma: Possible association with non-B non-C hepatitis pathogenesis.
    Konishi H; Shirabe K; Nakagawara H; Harimoto N; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Oda Y; Maehara Y
    Cancer Sci; 2015 May; 106(5):542-9. PubMed ID: 25736100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troxerutin improves hepatic lipid homeostasis by restoring NAD(+)-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice.
    Zhang ZF; Fan SH; Zheng YL; Lu J; Wu DM; Shan Q; Hu B
    Biochem Pharmacol; 2014 Sep; 91(1):74-86. PubMed ID: 25026599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in Nonalcoholic Fatty Liver Disease: SIRT Family Regulates Mitochondrial Biogenesis.
    Zeng C; Chen M
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36008973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clock-NAD
    Aggarwal S; Trehanpati N; Nagarajan P; Ramakrishna G
    J Cell Physiol; 2022 Aug; 237(8):3164-3180. PubMed ID: 35616339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis.
    Xu F; Li Z; Zheng X; Liu H; Liang H; Xu H; Chen Z; Zeng K; Weng J
    Diabetes; 2014 Nov; 63(11):3637-46. PubMed ID: 24947350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of silent information regulator 1-serine/arginine-rich splicing factor 10-lipin 1 axis in the pathogenesis of alcohol fatty liver disease.
    Li Y; Zhou J
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1117-1125. PubMed ID: 28467182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirtuins and nonalcoholic fatty liver disease.
    Nassir F; Ibdah JA
    World J Gastroenterol; 2016 Dec; 22(46):10084-10092. PubMed ID: 28028356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Roles of SIRT1 in Alcoholic Liver Disease.
    Ren R; Wang Z; Wu M; Wang H
    Int J Biol Sci; 2020; 16(16):3174-3183. PubMed ID: 33162823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1.
    Wang Y; Zhu K; Yu W; Wang H; Liu L; Wu Q; Li S; Guo J
    Biochem Biophys Res Commun; 2017 Nov; 493(1):227-232. PubMed ID: 28899784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutaredoxin-1 Deficiency Causes Fatty Liver and Dyslipidemia by Inhibiting Sirtuin-1.
    Shao D; Han J; Hou X; Fry J; Behring JB; Seta F; Long MT; Roy HK; Cohen RA; Matsui R; Bachschmid MM
    Antioxid Redox Signal; 2017 Aug; 27(6):313-327. PubMed ID: 27958883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in mRNA expression of sirtuin 1 and sirtuin 3 in cats fed on high fat diet.
    Ishikawa S; Li G; Takemitsu H; Fujiwara M; Mori N; Yamamoto I; Arai T
    BMC Vet Res; 2013 Sep; 9():187. PubMed ID: 24073959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of SIRT1 and Its Roles in Inflammation.
    Yang Y; Liu Y; Wang Y; Chao Y; Zhang J; Jia Y; Tie J; Hu D
    Front Immunol; 2022; 13():831168. PubMed ID: 35359990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoic acid improves mitochondrial function in nonalcoholic steatosis through the stimulation of sirtuin 1 and sirtuin 3.
    Valdecantos MP; Pérez-Matute P; González-Muniesa P; Prieto-Hontoria PL; Moreno-Aliaga MJ; Martínez JA
    Obesity (Silver Spring); 2012 Oct; 20(10):1974-83. PubMed ID: 22327056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis.
    Kim HS; Xiao C; Wang RH; Lahusen T; Xu X; Vassilopoulos A; Vazquez-Ortiz G; Jeong WI; Park O; Ki SH; Gao B; Deng CX
    Cell Metab; 2010 Sep; 12(3):224-36. PubMed ID: 20816089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.